Endocrine Consequences of Performance-Enhancing Drug Misuse
Endocrine Pharmacology and Anti-Doping Considerations
Endocrine Consequences of Performance-Enhancing Drug Misuse
Misuse of performance-enhancing drugs can disrupt gonadal, metabolic, thyroid or adrenal regulation, depending on the agents involved.
Therapeutic effects and feedback
Endocrine medicines can replace deficient signals, activate or block receptors, or change hormone synthesis and metabolism. Physiological replacement differs from supraphysiological exposure. Dose, route, duration, comorbidities and feedback suppression influence both benefit and harm.
Specific considerations
Combining drugs complicates attribution, and persistent symptoms or abnormal results require clinical evaluation rather than an assumed predictable course of hormonal recovery.
Clinical and sporting context
Legitimate treatment and anti-doping eligibility are separate questions. The current prohibited list, route-specific rules and applicable TUE process must be checked through official sources. Mechanistic descriptions should not be used to design unsupervised performance-enhancing drug protocols.
Home
Academy
Site Map